Efficacy Of Botulinum Toxin In The Treatment Of Acne

Evaluation of Efficacy of Botulinum Toxin In The Treatment Of Acne Vulgaris: A Double-Blind Clinical Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230529058336N1

Enrollment

Registered

2023-06-12

Start date

2023-06-25

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris. Acne vulgaris

Interventions

Intervention group: patients with moderate to severe acne based on the GAGS criteria, which are examined in 6 areas in this system: forehead, right cheek, left cheek, nose, chin and upper body. First,

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Patients with moderate to severe Acne based on global acne grading system criteria Age between 18 and 55 years old

Exclusion criteria

Exclusion criteria: Older than 55 years old Younger than 18 years old Having a contraindication to receiving Botox Having needle phobia Pregnancy and breastfeeding

Design outcomes

Primary

Measure	Time frame
The number of active papules and pustules and comedones. Timepoint: The effect of botulinum toxin in the treatment of acne vulgaris is investigated in the follow-up of patients at the beginning of the study and at month two and month four. Method of measurement: Mexameter and photography device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParsa Shiri

Tehran University of Medical Sciences

Parsa.Shiri1995@gmail.com+98 21 4441 7432

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026